• United States -
    • English
    • Global
    • us
      United States
      English
    • Asia
    • zh.svg
      China - 中国
      简体中文 (Chinese) / English
    • Europe
    • de
      Germany
      Deutsch (German) / English
    • it
      Italy
      Italiano (Italian) / English
    • es
      Spain
      Español (Castilian Spanish) / English
    • uk
      United Kingdom
      English
    • North America
    • mx
      Mexico
      Español (Spanish) / English
    • us
      United States
      English
    • South America
    • ar
      Argentina
      Español (Spanish) / English
    • cl
      Chile
      Español (Spanish) / English
    • co
      Colombia
      Español (Spanish) / English
  • Customer Support
  • FLASH RT
    • Ultra-high Dose Rate (UHDR) FLASH Radiotherapy
    • FLASH-RT Clinical Studies
  • Electron RT for Skin Cancer
    • Electron Therapy for Skin Cancer
    • Sales Inquiries
  • IORT
    • Electron IORT Overview
    • Meet the Mobetron
    • Mobetron Treatment Locations
    • Pancreatic Cancer Treatment with Mobetron
    • Breast Cancer Treatment with Mobetron
    • Single-Fraction APBI with Mobetron
    • Boost with Mobetron
    • IORT Clinical Studies
    • Mobetron Clinical Studies
    • Customer Support
    • Sales Inquiries
  • Healthcare Professionals
    • Healthcare Professionals Overview
    • Dermatologists
    • Surgical Oncologists
    • Radiation Oncologists
    • Hospital Administrators
    • Insurance Companies
  • Patients
    • Cancer Patients + Families
    • Patient Success Stories
  • IntraOp
    • About IntraOp
    • News and Events
  • Contact
    • Contact IntraOp
    • Sales Inquiries
    • Customer Support
  • Home
  • FLASH Radiotherapy
    • Ultra-high Dose Rate (UHDR) FLASH Radiotherapy
    • FLASH-RT Clinical Studies
  • Electron Therapy for Skin Cancer
    • Electron Therapy for Skin Cancer
    • Sales Inquiries
  • Mobetron IORT
    • Electron IORT Overview
    • Mobetron Treatment Locations
    • Mobetron Clinical Studies
    • Pancreatic Cancer Treatment with Mobetron
    • Breast Cancer Treatment with Mobetron
    • Single-Fraction APBI with Mobetron
    • Boost with Mobetron
    • IORT Clinical Evidence
    • Customer Support
    • Sales Inquiries
  • Healthcare Professionals
    • Healthcare Professionals Overview
    • Dermatologists
    • Surgical Oncologists
    • Radiation Oncologists
    • Hospital Administrators
    • Insurance Companies
  • Patients
    • Cancer Patients + Families
    • Patient Success Stories
  • IntraOp
    • About IntraOp
    • News and Events
  • Contact
    • Contact IntraOp
    • Sales Inquiries
    • Customer Support
  • Global
  • us Corporate English
  • Asia
  • zh.svg China - 中国 简体中文 (Chinese) / English
  • Europe
  • de Germany Deutsch (German) / English
  • it Italy Italiano (Italian) / English
  • es Spain Español (Castilian Spanish) / English
  • uk United Kingdom English
  • North America
  • mx Mexico Español (Spanish) / English
  • us United States English
  • South America
  • ar Argentina Español (Spanish) / English
  • cl Chile Español (Spanish) / English
  • co Colombia Español (Spanish) / English

Proven Cancer Indications: Head and Neck

Home > Head and Neck
June 15, 2011

Zeidan, Y. et al., “Intraoperative radiation therapy for advanced cervical metastasis: A Single-Institution Experience.” (2011)

Treatment Use

Electron IORT

Cancer Indication

Head and Neck

Number of Patients

231

Summary/Conclusion

IORT results in effective local disease control at acceptable levels of toxicity. Our results support the
initiation of a phase III trial comparing outcomes for patients with cervical metastasis treated with or without IORT.

Read More
February 17, 2011

Zeidan, Y. et al., “Intraoperative Radiotherapy for Parotid Cancer: A Single-Institution Experience.” (2011)

Treatment Use

Electron IORT

Cancer Indication

Head and Neck

Number of Patients

96

Summary/Conclusion

IORT results in effective local disease control at acceptable levels of toxicity and should be considered for patients with primary or recurrent cancer of the parotid gland.

Read More
August 17, 2006

Chen, A. et al., “Intraoperative Radiation Therapy for Recurrent Head and Neck Cancer-The UCSF Experience.” (2007)

Treatment Use

Mobetron

Cancer Indication

Head and Neck

Number of Patients

137

Summary/Conclusion

IORT results in effective disease control with acceptable toxicity and should be considered for selected patients with recurrent or persistent cancers of the head and neck.

Read More

View Clinical research and studies by

  • Proven Cancer Indications
    • Breast (Boost)
    • Breast (Single-Fraction APBI)
    • Colorectal
    • Gynecological
    • Head and Neck
    • Pancreatic
    • Sarcoma
    • Skin
  • Emerging Cancer Indications
    • Brain
    • Esophageal
    • Gastric
    • Genitourinary
    • Lung
    • Pediatric
    • Prostate
    • Skin
    • Spinal Metastases
  • FLASH Radiotherapy
    • Electron-beam FLASH
IntraOp Corporate HQ

IntraOp Medical Corporation
448 Kato Terrace
Fremont CA 94539

+1 408.636.1020

Contact IntraOp
  • Customer Support
  • General Inquiries
  • Sales Inquiries
Latest News
  • On-Demand Webinar: IORT Advancements in Cancer Treatments
2025 © All rights reserved. IntraOp Medical, Inc.
  • Privacy and Terms
  • Sitemap